PMID: 8950391Oct 1, 1996Paper

Autologous transplantation of nasal mucosa after severe chemical and thermal eye burns

Acta Ophthalmologica Scandinavica
R KuckelkornM Reim

Abstract

Between February 1992 and March 1994, reconstruction of the fornices in 17 patients with extensive symblephara or lid fusion after most severe eye burns was performed with nasal mucosa from the inferior conchae as graft material. The time between accident and transplantation ranged from 2-64 months. All patients were followed for 6 to 31 months. Reconstruction of the fornices was achieved in 13 patients. Postoperative Schirmer-tests revealed markedly improved results. Impression cytology showed a persistence of goblet-cells and an excess of mucus. We have subsequently performed keratoplasties in 5 of these patients and are planning penetrating keratoplasties in a further 8 cases. In 4 patients, partial symblepharon formation recurred within 2-3 months after transplantation of nasal mucosa. The main advantage of nasal mucosa over buccal or labial mucosa may be the transplantation of intraepithelial goblet cells, leading to an improvement and stabilisation of the tear film.

References

Sep 1, 1979·American Journal of Ophthalmology·H E Kaufman, E L Thomas
Dec 1, 1990·Klinische Monatsblätter für Augenheilkunde·V RossaP Heering
Jun 15, 1989·American Journal of Ophthalmology·G B Bartley, P P Kay
May 1, 1989·Ophthalmology·K R Kenyon, S C Tseng
Jan 1, 1988·International Ophthalmology Clinics·J B Mattax, J P McCulley
Aug 1, 1986·The British Journal of Ophthalmology·E G Kemp, J R Collin
Mar 1, 1968·Archives of Ophthalmology·C H DohlmanA Gasset
Jan 1, 1969·The British Journal of Ophthalmology·M Merz, W Czerwińska
May 1, 1982·American Journal of Ophthalmology·R W NeuhausN Shorr
Apr 1, 1982·Ophthalmology·R A Thoft
Mar 11, 1995·Lancet·R KuckelkornM Reim
Jun 1, 1993·Klinische Monatsblätter für Augenheilkunde·R KuckelkornM Reim
Feb 1, 1993·Klinische Monatsblätter für Augenheilkunde·R KuckelkornM Reim
Jul 1, 1959·Plastic and Reconstructive Surgery and the Transplantation Bulletin·R CASTROVIEJO
Sep 1, 1960·The British Journal of Ophthalmology·S ERBAKAN

❮ Previous
Next ❯

Citations

Jun 10, 2011·Acta Ophthalmologica·Ho-Seok SaYoon-Duck Kim
Nov 1, 2011·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·H G Struck, N F Schrage
Nov 1, 2011·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·B Bachmann, C Cursiefen
Nov 5, 2011·Veterinary Ophthalmology·Esmeralda Delgado
Jun 7, 2011·Cornea·Sheraz M DayaUNKNOWN Members of The Cornea Society Ocular Surface Procedures Nomenclature Committee
Jan 11, 2014·Current Eye Research·Yaqing FengGerd Geerling
Feb 15, 2011·European Journal of Ophthalmology·Yeoun Sook ChunJae Chan Kim
Dec 5, 2009·Current Eye Research·Stefan SchraderGerd Geerling
Feb 17, 2017·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·M FuestJ S Mehta
Jun 15, 2021·American Journal of Ophthalmology Case Reports·Hernan Martinez-OsorioLuz Stella Marin-Muñoz
Jun 14, 2021·The Ocular Surface·Aruni K MakuloluwaStephen B Kaye

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.